The FDA has approved Cabometyx (cabozantinib) for previously treated, unresectable, locally advanced or metastatic, well-differentiated neuroendocrine tumors.

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection) for use in patients with prostate cancer.

Americans living in rural communities could see their access to health care diminish if Congress changes eligibility for Medicaid or significantly reduces funding.

A fake web page designed to look like the CDC vaccine safety site has been taken down on orders from HHS secretary Robert F. Kennedy Jr.

Patients with MSI-H mCRC had a higher probability of survival with first-line ICI therapy than with chemotherapy, but second-line or later ICIs did not confer the same benefit.

Researchers proposed changing the recommendations for universal driving restrictions after CAR T-cell infusion.

Childhood cancer survivors “may experience considerable accelerated aging throughout their lifespan,” the researchers wrote.

Our data clearly show that it is feasible and safe to implement stepwise acceleration of nivolumab and pembrolizumab administration to a 10-minute infusion time,” the researchers wrote.

Barriers to wider use of AI in oncology include inaccuracy, workflow challenges, environmental impacts, and more.

The FDA has accepted the resubmitted BLA for linvoseltamab for patients with relapsed/refractory multiple myeloma.

Repeat biopsies in patients with TNBC may detect changes in HER2 status and allow more patients to gain access to T-DXd, data suggest.

High intake of sugar-sweetened beverages is associated with an increased risk of oral cavity cancer in women, data suggest.